These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
9. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. Porter JD; Rafael JA; Ragusa RJ; Brueckner JK; Trickett JI; Davies KE J Cell Sci; 1998 Jul; 111 ( Pt 13)():1801-11. PubMed ID: 9625743 [TBL] [Abstract][Full Text] [Related]
10. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Deconinck AE; Rafael JA; Skinner JA; Brown SC; Potter AC; Metzinger L; Watt DJ; Dickson JG; Tinsley JM; Davies KE Cell; 1997 Aug; 90(4):717-27. PubMed ID: 9288751 [TBL] [Abstract][Full Text] [Related]
11. [Utrophin, a way to cure Duchenne muscle dystrophy]. Gillis JM Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117 [TBL] [Abstract][Full Text] [Related]
12. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761 [TBL] [Abstract][Full Text] [Related]
13. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Matsumura K; Ervasti JM; Ohlendieck K; Kahl SD; Campbell KP Nature; 1992 Dec; 360(6404):588-91. PubMed ID: 1461282 [TBL] [Abstract][Full Text] [Related]
14. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM Nat Med; 1997 Nov; 3(11):1216-21. PubMed ID: 9359695 [TBL] [Abstract][Full Text] [Related]
15. Myotendinous junction defects and reduced force transmission in mice that lack alpha7 integrin and utrophin. Welser JV; Rooney JE; Cohen NC; Gurpur PB; Singer CA; Evans RA; Haines BA; Burkin DJ Am J Pathol; 2009 Oct; 175(4):1545-54. PubMed ID: 19729483 [TBL] [Abstract][Full Text] [Related]
16. Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. Law DJ; Tidball JG Am J Pathol; 1993 May; 142(5):1513-23. PubMed ID: 8494050 [TBL] [Abstract][Full Text] [Related]
17. Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue. Haenggi T; Fritschy JM Cell Mol Life Sci; 2006 Jul; 63(14):1614-31. PubMed ID: 16710609 [TBL] [Abstract][Full Text] [Related]
18. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791 [TBL] [Abstract][Full Text] [Related]
19. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Fisher R; Tinsley JM; Phelps SR; Squire SE; Townsend ER; Martin JE; Davies KE Neuromuscul Disord; 2001 Nov; 11(8):713-21. PubMed ID: 11595513 [TBL] [Abstract][Full Text] [Related]